99%+ Purity
COA Included
Sealed Vials
PE-22-28
Neurogenesis peptide for cognitive enhancement
Neurogenesis and cognitive enhancement
Key Benefits
- May support new neuron growth
- Potentially enhances cognitive function
- Research suggests improved synaptic plasticity
- May promote neuronal survival pathways
- Could support healthy neuroinflammatory response
- Targets brain-derived neurotrophic factor signaling
- May enhance hippocampal neurogenesis
Think Faster, Remember More, Build New Brain Cells
Your brain stops making new neurons as you age—that's why thinking gets slower and memory gets fuzzy. PE-22-28 is designed to restart that neurogenesis process, giving you the mental sharpness and recall you had in your twenties. Instead of accepting cognitive decline, you're actually building new neural pathways.
Neurogenesis pathway / BDNF signaling cascade (hippocampal neuron formation, synaptic plasticity)
About PE-22-28
PE-22-28 is a synthetic neurogenesis peptide that targets brain-derived neurotrophic factor pathways to promote new neuron growth and enhance cognitive function. It works by activating the cellular machinery responsible for creating fresh neural connections in areas of the brain critical for memory and learning. The peptide is specifically designed to support hippocampal neurogenesis while promoting overall brain plasticity.
Who It's For
This peptide is for high-performers who need their cognitive edge maintained or restored—executives, entrepreneurs, and anyone whose livelihood depends on mental acuity. PE-22-28 represents a proactive approach to brain health, potentially preventing age-related cognitive decline while enhancing current mental performance. It integrates well with comprehensive longevity protocols focused on maintaining peak neurological function throughout aging.
Research Background
PE-22-28 represents an investigational peptide in the emerging field of neurogenesis enhancement, though comprehensive research data remains limited. The compound is designed to potentially stimulate the growth of new neurons and improve cognitive function by targeting key brain signaling pathways involved in neuroplasticity and synaptic connectivity. Research in this area focuses on understanding how specific peptide sequences can influence brain-derived neurotrophic factor (BDNF) pathways, which are crucial for neuron survival and growth.
Current research priorities include: 1) Establishing optimal peptide design for brain penetration, 2) Understanding long-term safety profiles, and 3) Determining effective dosing strategies. The field faces significant challenges related to blood-brain barrier penetration and peptide stability, which are common obstacles in neurological drug development. While the concept of pharmacologically enhancing neurogenesis shows promise in laboratory settings, translation to human applications requires extensive safety and efficacy validation through rigorous clinical research protocols.
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
PE-22-28
$40.00